Godavari Biorefineries in FY26: Recovery, mix shift, and a June 2026 capacity inflection

Godavari Biorefineries Limited closed FY26 with a mix of steady growth, a return to positive full-year profitability, and a clear focus on building an integrated bio-based platform that can stay competitive in a volatile energy and logistics environment. The year was framed by management as a period of resilience and strategic progress, even as sector economics remained heavily influenced by government-set ethanol pricing and sugarcane cost inflation.

For FY26, consolidated total income came in at 2,000.2 crore, up 6.0% year-on-year. EBITDA increased 15.8% to 139.3 crore, with EBITDA margin improving to 7.0% from 6.4% in FY25. Profit after tax for FY26 was 3.5 crore, compared to a loss in FY25. Finance costs fell sharply to 49.1 crore from 71.8 crore, a drop that management linked to the 240 crore debt repayment carried out in FY25.

Quarter 4 showed a sharp sequential rebound, driven largely by sugar seasonality and operating leverage. Q4 FY26 revenue from operations stood at 564.1 crore and EBITDA was 92.1 crore, translating into a 16.2% margin. PAT for Q4 FY26 was 52.9 crore.

Segment performance: ethanol and chemicals grew, while Q4 chemicals margins softened

Godavari’s core business remains an integrated model spanning sugar, co-generation, ethanol, and bio-based chemicals. The company also highlighted its consumer brand, Jivana, as an emerging growth driver.

In FY26, the company disclosed a consolidated revenue mix of 36% from sugar and cogeneration, 33% from ethanol, 29% from bio-based chemicals, and about 1% unallocated. Segment revenues for FY26 were 724.6 crore for sugar and cogeneration, 658.6 crore for ethanol, and 578.0 crore for bio-based chemicals.

The bio-based chemicals segment continued to move toward a higher specialty contribution over the full year. Specialty chemicals and others rose to 61% of segment revenue in FY26 from 58% in FY25. Segment revenue grew 6.6% to 578.0 crore. EBITDA improved to 47.8 crore from 37.8 crore, and EBITDA margin expanded to 8.3% from 7.0%.

But Q4 highlighted the operational reality that a specialty transition is not always linear. Bio-based chemicals revenue rose 5.9% year-on-year to 147.4 crore, but EBITDA declined to 9.5 crore from 13.5 crore. EBITDA margin slipped to 6.5% from 9.7%. The presentation noted that geopolitical disruptions impacted specialty chemical sales, and management later confirmed on the concall that freight and some raw material supply issues increased costs.

The integrated sugar, ethanol, and co-generation segment delivered FY26 revenue of 1,383.2 crore, up 5.8% year-on-year, with EBITDA rising 19.3% to 97.4 crore. Q4 segment revenue declined 5.6% to 411.4 crore, but the quarter still showed strong sequential recovery, driven by peak crushing operations.

Ethanol was a key growth engine during the year. Ethanol revenue rose 12.6% year-on-year to 658.6 crore. The company sold 98 million litres of ethanol equivalent in FY26, with the mix disclosed as 81% under the ethanol blending programme, 13% ENA, and 6% others.

Jivana continued to scale. FY26 revenue was 129 crore, with the company stating a three-year CAGR of 44% and retail reach of 7,500 plus stores. The four-pillar slide also described a 19% year-on-year growth for the brand, though a base for that percentage was not shown in the deck.

June 2026 grain distillery: flexibility for EBP and captive chemicals demand

The most time-bound operational milestone discussed was the commissioning of a 200 KLPD fungible grain or maize distillery. The presentation stated commissioning by June 2026 and described it as adding about 60 million litres of annual ethanol capacity. On the concall, management said most equipment is on site, the plant is largely erected, and commissioning trials were targeted for June 2026.

The strategic rationale has two layers.

First, it adds capacity aligned to India’s policy momentum. The company highlighted the ethanol blending roadmap and referenced draft standards for blending beyond E20, positioning this as structural demand support for ethanol.

Second, it adds feedstock and channel flexibility. Management repeatedly described a multi-feedstock and multi-product approach as a way to reduce climate, policy, and feedstock risks. They also indicated that ethanol produced can support captive requirements for the chemicals business, especially when imported ethanol becomes more expensive during geopolitical disruptions.

While investors pushed for project economics, management did not provide capex, asset turns, or EBITDA potential. They noted that clearer visibility would depend on the government’s blending targets and pricing decisions expected around September or October 2026, as well as crop and feedstock pricing outcomes.

Margin sensitivity: cane pricing, ethanol pricing, and logistics shocks

The concall responses were consistent in acknowledging that parts of the profit equation remain policy-driven. Management cited margin pressure due to an increased sugarcane price without a corresponding increase in sugar MSP or ethanol blend price. On ethanol, they emphasized that selling prices are declared by the government by feedstock category and are common across the industry.

The company also highlighted a shift in the chemicals market backdrop. Management argued that the West Asia crisis created a scenario where fossil-linked energy and import costs rise, while Godavari’s bagasse-based energy model remains relatively stable. This is seen as improving competitiveness both in export markets and in import substitution within India. At the same time, they acknowledged that the disruption increased freight costs and created supply issues for some raw materials, affecting chemicals margins.

A more subtle point from the call was management’s willingness to shift product mix within chemicals based on near-term economics. They reiterated that the long-term goal is to increase bio-based specialty chemicals, but also noted that when ethyl acetate margins are attractive, they can use ethanol internally to capture those opportunities, particularly in periods where ethanol supply exceeds demand.

Cash flow and balance sheet: operating cash improved, capex cycle continued

FY26 cash flow showed a meaningful improvement in operating cash generation. Net cash from operating activities was 171.3 crore versus a small outflow in FY25. Investing cash flow was negative 162.6 crore, consistent with a year of elevated capital expenditure.

On the balance sheet, capital work-in-progress rose to 129.3 crore at March 2026 from 22.2 crore, aligning with ongoing project execution. Total assets increased to 2,052.3 crore. Total equity stood at 788.3 crore.

Borrowings showed a shift in maturity profile. Non-current borrowings increased to 333.3 crore from 239.7 crore, while current borrowings declined to 196.8 crore from 249.7 crore. The company also highlighted lower finance costs in the P&L and attributed the broader reduction to debt repayment completed in FY25.

Takeaways from FY26

Godavari Biorefineries exited FY26 with improving operating momentum, a return to positive full-year PAT, and a clearer near-term milestone in the form of a June 2026 grain distillery commissioning. Segment data suggests ethanol and bio-based chemicals both contributed to growth, while sugar and co-generation remained steady at the yearly level.

The key debate for investors is likely to remain around margin durability. Management’s comments underline two realities. One, policy decisions on cane pricing, sugar MSP, and ethanol prices can compress or expand profitability without much warning. Two, geopolitical shocks can both hurt and help, raising logistics costs while improving competitiveness for an integrated bio-based producer.

If the distillery commissioning proceeds as guided and the company is able to translate FY26 debottlenecking efforts into higher chemicals penetration from FY27 onward, the operating model becomes more flexible. The near-term performance will still be influenced by regulated pricing and external volatility, but FY26 shows that the company is working to build resilience across feedstock, product mix, and end markets.